Previous close | 2,022.50 |
Open | 2,385.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 2,342.00 - 2,401.35 |
52-week range | 1,277.60 - 2,524.00 |
Volume | |
Avg. volume | 158,503 |
Market cap | 400.517B |
Beta (5Y monthly) | 0.22 |
PE ratio (TTM) | 75.75 |
EPS (TTM) | 31.15 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 32.00 (1.58%) |
Ex-dividend date | 30 Jun 2023 |
1y target est | 2,011.00 |
(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.Most Read from BloombergChina Attempts to End Property Crisis With Broad Rescue PackageWith a BlackRock CEO, $9 Trillion Vanguard Braces for TurbulenceUS Inflation Data Was Accidentally Released 30 Minutes EarlyPutin and Xi Vow to Step Up Fight to Counter US ‘Containment’Jamie Dimon Sees ‘Lot of Inflationary Forces in Front of
GSK PLC (NYSE:GSK) recently announced a dividend of $0.38 per share, payable on July 11, 2024, with the ex-dividend date set for May 16, 2024. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Utilizing the data from GuruFocus, let's delve into GSK PLC's dividend performance and assess its sustainability.
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th